The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis.

作者: Elizabeth Gray , James R. Larkin , Tim D. W. Claridge , Kevin Talbot , Nicola R. Sibson

DOI: 10.3109/21678421.2015.1053490

关键词: Biomarker (medicine)Cerebrospinal fluidNervous systemAmyotrophic lateral sclerosisMetabolomicsCellular pathologyCase-control studyNeurochemicalPathologyMedicine

摘要: Neurochemical biomarkers are urgently sought in ALS. Metabolomic analysis of cerebrospinal fluid (CSF) using proton nuclear magnetic resonance ((1)H-NMR) spectroscopy is a highly sensitive method capable revealing nervous system cellular pathology. The (1)H-NMR CSF metabolomic signature ALS was longitudinal cohort. Six-monthly serial collection performed patients across range clinical sub-types (n = 41) for up to two years, and healthy controls at single time-point 14). A multivariate statistical approach, partial least squares discriminant analysis, used determine differences between the NMR spectra from controls. Significantly predictive models were found those with one year's interval recruitment second sample. Glucose, lactate, citric acid and, unexpectedly, ethanol discriminating metabolites elevated It concluded that captured associated derangements energy utilization connected ALS, most prominent comparisons longer disease duration. specific identified support concept hypercatabolic state, possibly involving mitochondrial dysfunction specifically. Endogenous may be an unrecognized novel marker neuronal tissue injury

参考文章(31)
E J Kasarskis, S Berryman, J G Vanderleest, A R Schneider, C J McClain, Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. The American Journal of Clinical Nutrition. ,vol. 63, pp. 130- 137 ,(1996) , 10.1093/AJCN/63.1.130
Anna Wuolikainen, Thomas Moritz, Stefan L. Marklund, Henrik Antti, Peter Munch Andersen, Disease-Related Changes in the Cerebrospinal Fluid Metabolome in Amyotrophic Lateral Sclerosis Detected by GC/TOFMS PLoS ONE. ,vol. 6, pp. e17947- ,(2011) , 10.1371/JOURNAL.PONE.0017947
I. R. McManus, A. O. Contag, R. E. Olson, Characterization of Endogenous Ethanol in the Mammal. Science. ,vol. 131, pp. 102- 103 ,(1960) , 10.1126/SCIENCE.131.3393.102
Jeffrey D. Rothstein, Lee J. Martin, Ralph W. Kuncl, Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral Sclerosis The New England Journal of Medicine. ,vol. 326, pp. 1464- 1468 ,(1992) , 10.1056/NEJM199205283262204
Thomas Skov, Frans van den Berg, Giorgio Tomasi, Rasmus Bro, Automated alignment of chromatographic data Journal of Chemometrics. ,vol. 20, pp. 484- 497 ,(2006) , 10.1002/CEM.1031
Claire L Waterman, Richard A Currie, Lisa A Cottrell, Jacky Dow, Jayne Wright, Catherine J Waterfield, Julian L Griffin, An integrated functional genomic study of acute phenobarbital exposure in the rat BMC Genomics. ,vol. 11, pp. 9- 9 ,(2010) , 10.1186/1471-2164-11-9
A.W. Jones, G. Mårdh, E. Änggård, Determination of endogenous ethanol in blood and breath by gas chromatography-mass spectrometry Pharmacology, Biochemistry and Behavior. ,vol. 18, pp. 267- 272 ,(1983) , 10.1016/0091-3057(83)90184-3
M. Benatar, J. Wuu, Presymptomatic studies in ALS: Rationale, challenges, and approach Neurology. ,vol. 79, pp. 1732- 1739 ,(2012) , 10.1212/WNL.0B013E31826E9B1D
Sandra R. Bacman, Walter G. Bradley, Carlos T. Moraes, Mitochondrial Involvement in Amyotrophic Lateral Sclerosis: Trigger or Target? Molecular Neurobiology. ,vol. 33, pp. 113- 132 ,(2006) , 10.1385/MN:33:2:113
Robert Bowser, Martin R. Turner, Jeremy Shefner, Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations. Nature Reviews Neurology. ,vol. 7, pp. 631- 638 ,(2011) , 10.1038/NRNEUROL.2011.151